Delivery Order SPE2DB20D7061-SPE2DB23FSNH1
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,480.56 firm fixed-price delivery order is for TNKASE 50 MG KITS, with a period of performance through December 26, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,163.82, is for the delivery of 4566477620 ! TNKASE 50 MG KITS, a medical supply product. The contract has an ultimate completion date of November 19, 2024, and was awarded on November 18, 2024. The award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $4,581.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TNKASE 50 MG KITS, a medical product, and has a completion date of February 2, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,093.90, is a Firm Fixed Price Delivery Order for the supply of 4560863049 TNKASE 50 MG KITS. The contract has an ultimate completion date of May 9, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,163.82 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of 4,563,486,792 TNKASE 50 MG KITS, a pharmaceutical product, with a performance period ending on January 31, 2024. The contract is a Firm Fixed Price arrangement and was awarded on January 30, 2024 without any set-aside...
- This federal contract award, valued at $9,163.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of TNKASE 50 MG KITS, a pharmaceutical product, to the federal government. There is no...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TNKASE 50 MG KITS, a medical product, with a ceiling value of $9,875.17. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,163.82 firm fixed price delivery order is for the supply of TNKASE 50 MG KITS, a specialty pharmaceutical product. The contract has an ultimate completion date of March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,745.76 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565354916 ! TNKASE 50 MG KITS. This contract has an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- This federal contract award, valued at $10,206.61, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4563527257 TNKASE 50 MG KITS, a pharmaceutical product. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB23FSNH1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,186.05 firm-fixed-price delivery order is for the supply of TNKASE 50 MG KITS medical products. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC serves as the primary vehicle for efficiently procuring essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., which operates under the Amerisourcebergen brand, also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 4/1/23 |